FDA Warns of Seizure, Alcohol Risk With Chantix
The FDA has changed the labeling on the quit-smoking drug Chantix to reflect concerns that it may lower your tolerance to alcohol and is linked to a rare risk of seizures. (Source: WebMD Health)
Source: WebMD Health - March 10, 2015 Category: Consumer Health News Source Type: news
Morning Break: No Reprieve for Chantix; Rx Spending Spike
(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff. (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 10, 2015 Category: American Health Source Type: news
U.S. FDA warns of seizure, alcohol risk with Pfizer's Chantix
(Reuters) - The U.S. Food and Drug Administration warned on Monday that Pfizer Inc's quit-smoking drug, Chantix, has been associated with seizures and that some patients who drink while taking the drug may become aggressive or black out. (Source: Reuters: Health)
Source: Reuters: Health - March 9, 2015 Category: Consumer Health News Tags: healthNews Source Type: news
Chantix (varenicline): Drug Safety Communication - FDA Updates Label to Include Potential Alcohol Interaction
Rare risk of seizures, and studies of side effects on mood, behavior, or thinking. Posted 03/09/2015 (Source: FDA MedWatch)
Source: FDA MedWatch - March 9, 2015 Category: American Health Source Type: news
Chantix May Lower Alcohol Tolerance, Up Seizure Risk: FDAChantix May Lower Alcohol Tolerance, Up Seizure Risk: FDA
The FDA has changed the labeling on the smoking cessation medication Chantix to reflect concerns that the drug may lower alcohol tolerance and boost seizure risk. News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 9, 2015 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Stop-Smoking Drug Helps HIV Patients Kick Habit (CME/CE)
(MedPage Today) -- But success rates with varenicline were still low. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 1, 2015 Category: Cardiology Source Type: news
Cardiac Regeneration/Stop-Smoking Drug/Juicing: Mayo Clinic Radio
On this week’s Mayo Clinic Radio: fixing a broken heart. Cardiac regeneration uses the body’s own stem cells to repair damage done by heart disease, Mayo Clinic cardiologist Dr. Atta Behfar explains. Also, Mayo Clinic registered dietitian Katherine Zeratsky explains the risks of juice-only diets. Plus, nicotine dependency expert Dr. Richard Hurt joins the program to discuss results of a new study about the stop-smoking drug varenicline (Chantix). Click here [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 23, 2015 Category: Databases & Libraries Source Type: news
Mayo clinic radio
On this week’s Mayo Clinic Radio: fixing a broken heart. Cardiac regeneration uses the body’s own stem cells to repair damage done by heart disease, Mayo Clinic cardiologist Dr. Atta Behfar explains. Also, Mayo Clinic registered dietitian Katherine Zeratsky explains the risks of juice-only diets. Plus, nicotine dependency expert Dr. Richard Hurt joins the program to discuss results of a new study about the stop-smoking drug varenicline (Chantix). Myth or [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 20, 2015 Category: Databases & Libraries Source Type: news
Drug may help people gradually quit smoking
Anti-smoking drug Chantix can help smokers cut back, but "its success comes with a cost" -- serious side effects (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - February 18, 2015 Category: Consumer Health News Source Type: news
Chantix Linked to Higher Quit Rates in Certain Smokers: Study
Title: Chantix Linked to Higher Quit Rates in Certain Smokers: StudyCategory: Health NewsCreated: 2/17/2015 12:00:00 AMLast Editorial Review: 2/18/2015 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 18, 2015 Category: Respiratory Medicine Source Type: news
Varenicline May Be an Option for Smokers Who Aren't Willing to Quit Just Yet (FREE)
By Kelly Young
Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM
Varenicline (Chantix) leads to higher smoking cessation rates among smokers who say they're not quite ready to quit, according to an industry-funded study in … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - February 18, 2015 Category: Primary Care Source Type: news
Chantix Linked to Higher Quit Rates in Certain Smokers: Study
But drug's side effects still worry some doctors (Source: WebMD Health)
Source: WebMD Health - February 17, 2015 Category: Consumer Health News Source Type: news
Chantix Linked to Higher Quit Rates in Certain Smokers
But drug's side effects still worry some doctors
Source: HealthDay
Related MedlinePlus Pages: Medicines, Quitting Smoking (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 17, 2015 Category: Consumer Health News Source Type: news
Medicine Given Even Before Smokers Are Ready to Quit Is Found to Help Them
A study has found that even for people who are not ready to stop smoking immediately, medicine taken over time can improve their chances of eventually quitting. (Source: NYT Health)
Source: NYT Health - February 17, 2015 Category: Consumer Health News Authors: By SABRINA TAVERNISE Tags: Nicotine Chantix Smoking and Tobacco Medicine and Health Pfizer Inc Source Type: news
Medication Therapy Can Increase Long-Term Success For Smokers Who Cut Back First
https://www.youtube.com/watch?v=1Dg5bncTJsg ROCHESTER, Minn. — A study of more than 1,500 cigarette smokers who were not ready to quit smoking but were willing to cut back on cigarette consumption and combine their approach with varenicline (Chantix) increased their long-term success of quitting smoking. The multinational study is published in the February issue of the Journal of [...] (Source: Mayo Clinic Rochester News)
Source: Mayo Clinic Rochester News - February 17, 2015 Category: Hospital Management Source Type: news
